Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

  1. Seijas-Amigo, J.
  2. Mauriz-Montero, M.J.
  3. Suarez-Artime, P.
  4. Gayoso-Rey, M.
  5. Reyes-Santías, F.
  6. Estany-Gestal, A.
  7. Casas-Martínez, A.
  8. González-Freire, L.
  9. Rodriguez-Vazquez, A.
  10. Pérez-Rodriguez, N.
  11. Villaverde-Piñeiro, L.
  12. Castro-Rubinos, C.
  13. Espino-Paisán, E.
  14. Cordova-Arevalo, O.
  15. Rodriguez-Penas, D.
  16. Cardeso-Paredes, B.
  17. Ribeiro-Ferreiro, M.
  18. Rodríguez-Mañero, M.
  19. Cordero, A.
  20. González-Juanatey, J.R.
Journal:
Diseases

ISSN: 2079-9721

Year of publication: 2024

Volume: 12

Issue: 10

Type: Article

DOI: 10.3390/DISEASES12100244 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus